Camp4 Therapeutics (CAMP) Gains from Investment Securities (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Gains from Investment Securities for 3 consecutive years, with -$191000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 28.73% to -$191000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$258000.0 through Dec 2025, down 95.45% year-over-year, with the annual reading at -$258000.0 for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities hit -$191000.0 in Q4 2025 for Camp4 Therapeutics, down from -$146000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.1 million in Q3 2024 to a low of -$268000.0 in Q4 2024.
  • Historically, Gains from Investment Securities has averaged $187607.8 across 3 years, with a median of $36000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: crashed 297.06% in 2024 and later surged 148.31% in 2025.
  • Year by year, Gains from Investment Securities stood at $136000.0 in 2023, then plummeted by 297.06% to -$268000.0 in 2024, then increased by 28.73% to -$191000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CAMP at -$191000.0 in Q4 2025, -$146000.0 in Q3 2025, and $43000.0 in Q2 2025.